Kolesnik, O. P. and Kuzmenko, V. O. (2020) “ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer”, Pathologia, (1). doi: 10.14739/2310-1237.2020.1.203639.